Current tetanus vaccines are based on inactivated tetanus toxin and are extremely effective in generating serum anti-toxin antibodies which protect against the highly potent neurotoxin released upon infection by Clostridium tetani (10) . However, three doses of an injectable vaccine are necessary, which is far from ideal in many developing countries where the logistics of storage, delivery, and compliance are complex. Consequently, there are an estimated 250,000 cases of tetanus per year, the majority of which are neonatal tetanus (4) . A novel vaccine that could be given by the oral, intranasal, or transdermal route could potentially reduce the burden of neonatal tetanus as well as provide a convenient booster for the adult population.
Tetanus toxin is a 150-kDa protein composed of three domains, each of approximately 50 kDa (21) ; the N-terminal L chain contains zinc endopeptidase activity (24) , the H N chain is involved in escape of the toxin from endocytotic vesicles, and the H C chain is involved in binding to cellular receptors (17, 25) . Tetanus toxin binds cell surface gangliosides and possibly a protein receptor, a process mediated solely through the H C chain (17, 25) . Structural analysis of H C , also termed fragment C, complexed with synthetic ganglioside reveals two distinct ganglioside binding sites on H C (8, 12) , termed the "Gal4-GalNAc3Ј" and "sialic acid" binding sites. Mutation of residues within or around these sites in H C results in decreased binding to gangliosides and to neuronal cells (23, 25) . The role of this cell binding in the interaction with immune cells, specifically antigen-processing cells, is unknown.
H C can induce protective antibodies in animals when given by a variety of delivery systems and routes, e.g., parenterally (19) , orally using an attenuated Salmonella delivery system (9) , as a plant vaccine (30) , or as a DNA vaccine (1). Both tetanus toxoid and H C also elicit protective responses after mucosal (6) and transcutaneous delivery using suitable adjuvants (29) . In one clinical study, attenuated strains of Salmonella enterica serovar Typhi expressing H C (2) given orally to human volunteers as a typhoid vaccine raised levels of serum antibody to tetanus toxoid in individuals who had low anti-tetanus titers at the start of the trial (28) . To this end, H C has been proposed as a possible replacement for the existing tetanus toxoid vaccine.
It has been recently argued that new vaccines against diphtheria and pertussis should be composed of recombinant, genetically inactivated toxin components (22) . A logical extension of this argument is to include a recombinant tetanus antigen, for example, H C , which would be expected to have clear advantages over toxoid in ease of production, characterization, and homogeneity. However, H C is known to bind to neuronal cells and is trafficked to higher centers in the central nervous system via retrograde axonal transport (3, 11) . While this does not appear to give rise to any obvious pathology, it would be highly preferable to use an antigen that lacked this activity and thus reduce any potential side effects if the protein were to be used as a human vaccine.
In this report, we compare the properties of tetanus toxoid with those of wild-type H C (H C WT) and mutant H C molecules containing deletions or single-site substitutions in the two ganglioside binding sites that are essential for retrograde transport to the central nervous system and assess their immunogenicities and protective capacities against tetanus toxin challenge in mice.
MATERIALS AND METHODS
Bacterial strains, plasmids, and molecular biology techniques. Escherichia coli BL21 was used as the host for all plasmids. Plasmid pKS1, encoding wild-type H C , and its derivatives encoding mutant proteins, H C M28 (⌬Gln 1274 -Pro 1279 ), H C M37 (⌬His 1271 -Asp 1282 ), and H C M58 (⌬Asp 1214 -Asn 1219 ), were described previously (25) . H C M115 (Arg 1226 Ala, Trp 1289 Ala) was constructed by site-directed mutagenesis of pKS1 using a QuikChange kit (Stratagene, Cambridge, United Kingdom) and the primers 5Ј CTGGACAGAATTCTGGCTGTTGGT TACAACGCT 3Ј, 5Ј AGCGTTGTAACCAACAGCCAGAATTCTGTCCAG 3Ј, 5Ј CTGATCGCTTCTAACGCTTACTTCAACCACCTG 3Ј, and 5Ј CAGG TGGTTGAAGTAAGCGTTAGAAGCGATCAG 3Ј.
Protein expression, purification, and characterization. Bacterial strains were grown in Luria-Bertani medium containing kanamycin (50 g/ml) where appropriate. Expression of proteins was induced by the addition of isopropyl-␤-Dthiogalactopyranoside (IPTG) to a final concentration of 1 mM. Cells were pelleted by centrifugation (5,500 ϫ g, 15 min) and lysed by sonication, and the His-tagged proteins were purified by nickel affinity chromatography as described previously (25) . Further purification was achieved by size exclusion chromatography using a Pharmacia Hiload 16/60 Superdex 200 preparatory-grade column. Endotoxin content was measured using the Limulus amoebocyte lysate microtest gelating assay (European Pharmacopoeia, 2005) using E. coli endotoxin as a reference (NIBSC 84/691). Protein concentrations were determined using the bicinchoninic acid assay (Pierce).
For optical spectroscopy, H C protein samples were dialyzed at 4°C into 10 mM sodium phosphate, pH 7.9. Absorbance maxima of the samples were determined at 279 nm (A 279 to A 350 ). Protein concentrations were calculated using theoretically determined extinction coefficients using the Mach equation (18) . For H C WT, the coefficient A 279 (absorbance at 0.1% [wt/vol]) of 1.695 liters g Ϫ1 cm Ϫ1 was used. Solutions of 0.5 ml were scanned in 1-cm-path-length quartz cuvettes from 500 nm to 240 nm.
Antibody binding. Direct enzyme-linked immunosorbent assays (ELISAs) were performed by coating proteins diluted in phosphate-buffered saline (PBS) overnight at 4°C onto microtiter plates (Maxisorp; Nunc) at 1 g/ml. After being washed with PBS containing 0.05% Tween 20, plates were blocked at 37°C with PBS containing 3% milk prior to the addition of serial dilutions of scFvH C 9 or TT10 antibody. TT10 is an anti-H C monoclonal antibody with toxin neutralization activity (32) . scFvH C 9 is a recombinant human single-chain antibody specific for H C (equilibrium dissociation constant for H C WT, approximately 90 nM). scFvH C 9 was isolated by antibody phage display against H C WT and inhibits binding of H C WT to GT1b gangliosides, as determined by ELISA (O. Qazi and N. Fairweather, unpublished data). After being washed, plates were incubated for 1 h with either horseradish peroxidase (HRP)-conjugated rabbit anti-rat immunoglobulin G (IgG) antibodies (DAKO) diluted 1 in 1,000 for TT10 visualization or mouse anti-9E10 antibodies (Mike Wright, Imperial College London, United Kingdom) diluted 1 in 5 for scFvH C 9 visualization. Plates incubated with scFvH C 9 were washed and incubated with HRP-conjugated rabbit antimouse antibodies (DAKO) for a further 1 h. Antibody binding was detected at 490 nm by the addition of o-phenylenediamine dihydrochloride (Sigma). Antibody concentrations yielding 50% maximum binding were calculated and are expressed as percentages of binding to H C WT. Capture ELISAs were performed by coating of plates with TT10 (100 l of 1 g/ml in carbonate buffer, pH 9.6) at 4°C overnight. After being washed and blocked as described above, plates were incubated for 2 h with doubling dilutions of test proteins. After plates were washed, 100 l purified guinea pig IgG anti-tetanus toxoid (4.75 g/ml) was added for 2 h at 37°C. After being washed, plates were incubated with HRPconjugated goat anti-guinea pig IgG (diluted 1 in 2,000) for 1 h, and binding was detected at 405 nm by the addition of ABTS [2,2Ј-azinobis(3-ethylbenzthiazolinesulfonic acid)] substrate.
Ganglioside binding ELISA. Ganglioside binding assays were performed as described previously (25) . Microtiter plates were coated with 0.5 g of bovine ganglioside GT1b per well (Sigma) and blocked with PBS containing 3% bovine serum albumin at 37°C, and H C proteins were added for 2 h. After being washed with PBS containing 0.05% Tween 20, plates were incubated for 1 h with polyclonal rabbit anti-H C antibodies (diluted 1 in 10,000), washed, and incubated for 1 h with HRP-conjugated goat anti-rabbit IgG antibodies (diluted 1 in 1,000; DAKO). Detection was at 490 nm after the addition of o-phenylenediamine dihydrochloride (Sigma). Calculated equilibrium dissociation constants were compared with that of H C WT to give percent binding values.
Intrinsic fluorescence spectroscopy. Fluorescence spectra were obtained using a Spex Fluoromax single-photon-counting spectrofluorometer at 23°C as described previously (14) using excitation wavelengths of 280 or 295 nm. Samples were diluted to approximately 2 g/ml in 1 ml of 10 mM sodium phosphate buffer, pH 7.9. Spectra were corrected by subtracting the corresponding buffer baseline spectra.
CD spectroscopy. Near-and far-UV circular-dichroism (CD) spectra were obtained using a Jasco J-720 spectropolarimeter (Jasco, Tokyo, Japan) at 20°C (Ϯ1°C) as described previously (14) . Samples contained between 1.3 and 1.9 mg/ml of H C protein. For secondary-structure analysis, the software programs Varslc1 (20) and Selcon (26, 27) were used. For Varslc1, CD data between 180 and 260 nm were used with a 33-protein basis set and default parameters; for Selcon, CD data between 190 and 250 nm were used with a 17-protein basis set (26, 27) and default parameters. The proportions of secondary-structure elements present in crystal structures were calculated using the DSSP (15) and XtlSSTR (16) computer programs.
PC12-H C cell binding assay. Rat pheochromocytoma (PC12) cells (Judit Herreros, Imperial College London, London, United Kingdom) were grown in Dulbecco's modified Eagle's medium containing 4 mg/liter glucose supplemented with 7.5% fetal calf serum, 7.5% horse serum, 100 g/ml penicillin, 100 g/ml streptomycin, and 4 mM L-glutamine. Glass coverslips coated with 5 g poly-D-lysine were placed in 24-well cell culture plates and 5 ϫ 10 4 PC12 cells added, followed by nerve growth factor (NGF) (75 ng/ml, 7S NGF; Alexis Corporation) after 1 to 2 days. H C proteins diluted to 5 g/ml in PBS containing 3% bovine serum albumin and 10% fetal calf serum were incubated with cells for 1 h at 4°C. Cells were fixed at room temperature for 15 min with 4% formaldehyde in PBS and incubated for 1 h with rabbit anti-H C (diluted 1 in 5,000), followed by incubation for 30 min with fluorescein isothiocyanate-conjugated swine anti-rabbit IgG antibodies (diluted 1 in 1,000; DAKO). Coverslips were washed and mounted onto slides, and cell binding was visualized using a Nikon Eclipse E600 fluorescent microscope.
Immunization and immunological analysis. Female NIH mice (18 to 22 g; Harlan, United Kingdom) were immunized subcutaneously with H C or tetanus toxoid (5,000 limit-of-flocculation units/ml, 12.5 mg/ml protein; NIBSC 01/126) in PBS on days 0 and 28 or 35 as indicated in the text. Sera were taken at day 35 or 42 and analyzed for the presence of anti-toxoid or anti-H C antibodies by ELISA. Plates were coated with antigen (0.1 g/ml H C or 0.5 limit-of-flocculation units [ϳ1.25 g/ml toxoid]). ELISA antibody levels were calculated for individual sera from groups of mice and were expressed in IU/ml in relation to the mouse reference reagent calibrated to the WHO International Standard. Mice were challenged on day 62 with 50 50% paralytic doses (PD 50 s) of tetanus toxin and survivors assessed after 4 days. Results were expressed as percentages of animals surviving challenge in relation to total number of mice treated. Results were expressed as geometric means per group with 95% confidence intervals. Comparisons between the groups were made using the Mann-Whitney test.
RESULTS
Immunization of mice with deletion mutants of H C . Preliminary mouse immunization experiments were conducted using H C WT and mutant proteins containing deletions in domains of H C required for ganglioside binding. H C M28 (⌬Gln 1274 -Pro 1279 ) and H C M37 (⌬His 1271 -Asp 1282 ) both contain deletions within the Gal4-GalNAc3 binding site, while H C M58 (⌬Asp 1214 -Asn 1219 ) contains a deletion within the sialic acid binding site (12, 25) . These deletions could well affect the immunogenicities of the proteins, for example, by subtly altering the structure of the protein or by direct loss of protective epitopes. Mutant proteins containing defined amino acid substitutions within the ganglioside binding sites were also constructed: H C M72, containing a Trp 1289 Ala substitution within the Gal4-GalNAc3 site; H C M64, containing an Arg 1226 Ala substitution within the sialic acid site; and H C M115, containing both mutations. Ganglioside GT1b binding activities were determined for all proteins. H C M28, H C M37, and H C M58 proteins had reduced ganglioside binding activities compared to H C WT, consistent with previous results (25) . Binding activities compared to those for H C WT were 12.5% for H C M64, 1.3% for H C M72, and Ͻ1% for H C M115 ( epitope that must encompass or lie near Arg 1226 , part of the sialic acid binding site.
The immunogenicities of the H C deletion proteins were compared with that of tetanus toxoid in a mouse protection study. Mice were given two subcutaneous doses of 0.5, 5, or 50 g of protein 28 days apart and serum samples taken 1 week after the second immunization (Fig. 1) . Antibodies to tetanus toxoid were determined by ELISA in sera from individual animals and calculated in IU/ml. Four weeks after the test bleeds, mice were directly challenged with tetanus toxin and the results expressed as percentages of animals showing protection (Fig. 1) . All H C proteins afforded complete protection against toxin challenge after two 50-g doses, but differences were observed between the proteins at lower doses. H C M37 gave no protection at the 0.5-g dose, and H C M28 and H C M58 gave 80% and 40% protection, respectively. All mutant H C proteins induced lower anti-tetanus toxoid responses than H C WT protein, with H C M37 giving the lowest antibody level and the lowest level of protection. Pooled mouse sera from the 5-g H C WT and toxoid groups were tested for protective antibodies in vivo using the mouse passive protection assay calibrated to the WHO International Standard for tetanus anti- . Consistent with the antibody response in ELISA to tetanus toxoid, the levels of functional antibodies in the sera of animals immunized with toxoid were 31 IU/ml (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) , approximately fourfold higher than those of animals immunized with H C WT, which induced a response of 9.5 (5.7 to 28.5) IU/ml. One possible reason for the lower immunogenicities of the mutant H C proteins could be structural instability. Using the 5.0-g dose, H C WT, H C M28, and H C M37 were treated with formaldehyde in an attempt to stabilize their structures. Treatment with 0.02% formaldehyde resulted in increased antibody levels for H C WT and H C M28 (P Ͻ 0.05) and retention of protection as determined by the mouse protection assay. However, neither an increase in antibody levels nor an increase in protection against challenge was seen for H C M37. Higher formaldehyde concentrations (0.2% and 2%) resulted in a loss of immunogenicity and reduced levels of protection, along with increased intermolecular cross-linking (our unpublished data).
Characterization of H C proteins containing defined changes within the ganglioside binding sites. The reduced ganglioside binding was expected to result in a decreased ability to bind to neuronal cells (13, 25) . Binding of H C WT to NGF-induced PC12 cells produced uniform staining of the neuronal processes and the cell membrane, displaying regions of punctate staining. In contrast, very little staining was evident with H C M64, H C M72, and H C M115, demonstrating that these proteins had very weak binding activities to PC12 cells compared with H C WT (Fig. 2) .
In order to determine whether the mutant H C proteins were folded in a manner similar to that of H C WT, intrinsic fluorescence and CD spectroscopy were employed. Intrinsic fluorescence spectroscopy demonstrated that H C WT, H C M64, H C M72, and H C M115 proteins displayed similar emission spectra, using an excitation wavelength of 280 or 295 nm. Fluorescence emission maxima of 328 nm for H C WT and 328 to 329 nm for the mutants were obtained. For tryptophan fluorescence (excitation wavelength, 295 nm), fluorescence emission maxima of 330 nm for H C WT and 330 to 331 nm for the H C mutants were found. Near-UV (250 to 320 nm) and far-UV (180 to 260 nm) CD spectra were collected for H C WT and for mutant H C proteins. Small but insignificant changes in the conformation or secondary-structure content of H C M115 (or the single-amino-acid mutant H C M64 or H C M72) compared to that of H C WT were apparent from the far-UV spectra (Fig. 3A) . The secondary-structure contents of H C WT and H C M115 proteins were determined from the far-UV CD spectra recorded ( Table 2 ). The proportions of secondary-structure elements present in the crystal structures of H C (8, 31) were also calculated for comparison using the DSSP (15) and XtlSSTR (16) programs. The secondary-structure calculations from the CD data differ slightly from the values calculated from the crystal structures. Taken together, these results indicate that there may be structural differences between H C WT and H C M115 but that these are likely to be minor. Analysis of the near-UV CD spectra (Fig. 3B) showed that H C M115 displayed a slightly less intense Tyr-Trp spectrum than either H C WT or H C M72. This could be indicative of structural destabilization surrounding the Gal4-GalNAc3 and sialic acid binding sites as a consequence of the mutations introduced.
Immunization of mice with ganglioside binding site mutants of H C . A second immunization study was carried out using the H C WT and H C M115 proteins. A size exclusion chromatography step was introduced following the Ni 2ϩ affinity chromatography to ensure that endotoxin levels were acceptable ( Table 1) . Groups of five mice were immunized subcutaneously with two doses of either 5 g or 0.5 g of H C WT or H C M115 35 days apart. Control groups were immunized with 5, 1, or 0.1 g of tetanus toxoid or with PBS alone. Sera from individual animals were then tested for the presence of antibodies to tetanus toxoid or H C protein (Fig. 4) . H C M115 induced an 80-to 100-fold-lower anti-H C response than H C WT at both 0.5-g and 5-g doses (P Ͻ 0.05 for both). A significant difference is also seen when the antitoxoid titers are compared, where a 20-to 200-fold-lower response was seen with H C M115 than with H C WT (P Ͻ 0.05 at the 5-g dose). The results were found to be dependent on the coating antigen used. When H C was used as the coating antigen, the titers for H C WT were approximately three times higher than those of tetanus toxoid, but these differences were not found to be significant. However, when toxoid was used as the coating antigen, the anti-toxoid titers were approximately four times greater than the anti-H C titers. These results were significant; responses to H C were significantly lower than responses to tetanus toxoid at doses of both 0.5 g and 5 g (P Ͻ 0.05 for both). Three weeks after the second immunization, mice were challenged with tetanus toxin (Fig. 4) . Complete protection was afforded to those mice immunized with 5 g or 0.5 g of H C WT, with 5 g of H C M115, or with 0.1 or 0.5 g of tetanus toxoid. a Two methods for secondary structure prediction were used, Varslc (20) and Selcon (26, 27) , and the calculated proportions for ␤ sheet, ␣ helix, turn, and other structures are shown. The proportions for secondary structure elements from two solved H C crystal structures are also included (8, 31) .
However, only 50% of mice receiving 0.5 g H C M115 survived the challenge, consistent with the lower titers of anti-H C and anti-toxoid generated by this group. Overall, the antibody responses were higher in this experiment than in the preliminary experiment (Fig. 1) . This is most likely due to the longer time between the primary immunization and the boost in the second experiment (Fig. 4) .
DISCUSSION
In this study, we compared the immunogenicities of wildtype H C protein, mutants of H C defective in ganglioside binding, and tetanus toxoid. H C holds considerable promise as a tetanus vaccine, particularly in formulations that can be given by the intranasal (5, 7) , transcutaneous, (29), or oral (28) route.
The evaluation of the immunogenicity of H C compared to that of toxoid is therefore of considerable importance. H C WT elicited protective antibodies as measured by direct toxin challenge and at all doses used (0.5, 5, and 50 g) provided full protection. The levels of anti-toxoid antibodies generated by H C were lower than those generated by toxoid on a weightfor-weight basis, but the levels of anti-H C antibodies did not vary significantly. Functional antibodies in sera of animals immunized with toxoid were approximately fourfold higher than those in sera of animals immunized with the same amount of H C WT protein, which induced a response of 9.5 (5.7 to 28.5) IU/ml, almost 1,000-fold higher than the level considered to confer full protection.
Mutants of H C lacking 6 amino acid residues (H C M28 and H C M58) with reduced ganglioside and cell binding activity showed reduced levels of protection at low doses of antigen compared to H C WT, but removal of 12 residues (H C M37) resulted in a more substantial reduction in both anti-toxoid antibodies and protection against toxin challenge. This reduced immunogenicity can most easily be explained by loss of epitopes and/or by structural alteration, although these were not formally tested here. Examination of the crystal structure of H C (8, 31) reveals that, although the residues deleted do not encompass helical or sheet regions, these mutant proteins nevertheless are unlikely to fold in exactly the same way as H C WT protein. The defined mutant H C M115, containing only two amino acid substitutions, had greatly reduced ganglioside binding and cell binding activities but surprisingly was significantly reduced in immunogenicity compared to H C WT. H C M115 had minimal structural differences compared to H C WT as determined by CD spectroscopy, and therefore, the reasons behind this reduced immunogenicity are uncertain, although H C M115 has lost at least one epitope that is recognized by the singlechain antibody scFvH C 9. The loss of ganglioside binding activity could interfere with interactions involving cellular receptors involved in antigen recognition or processing pathways. However, tetanus toxoid does not bind gangliosides or neuronal cells and is highly immunogenic. This raises the possibility that the mechanisms for inducing a protective response may be different between tetanus toxoid and H C protein. The ability of H C to bind gangliosides may be an important factor contributing to its stability, a parameter essential for induction of protective response to proteins, particularly by the subcutaneous route. As a general rule, proteins with high serum clearance rates and high susceptibilities to proteases are poorly immunogenic. Further experiments to determine the in vitro and in vivo stabilities of H C M115 would address these questions. For example, antigens could be incubated with serum and degradation monitored over a period of time by Western blot analysis. Robbins et al. (22) have argued that the current diphtheria and pertussis components should be replaced with genetically inactivated mutant toxins. This argument could be extended to all three components of the diphtheria-tetanuspertussis vaccine, and the data reported here support the notion that H C should be seriously considered as the nontoxic component of new diphtheria-tetanus-pertussis vaccines.
